3140 results for «3050»

Filter By

3140 results

CTO-PCI

07 Oct 2022 – From AICT-AsiaPCR 2022

Consider a 53-year-old man with a strong family history of MI, a history of exertion angina with cycling and dyslipidemia, or a 76-year-old male patient with hypertension, type 2 diabetes, previous CABG (2017), cholecystectomy (2018), left carotid endarterectomy (2018), left leg intervention (2018), and mild aortic...

CTO-PCI

Complex PCI with left ventricular support - Session with LIVE case

07 Oct 2022 – From AICT-AsiaPCR 2022

Look at this case of a 73-year-old man, heavy smoker, with hypertension, type 2 DM, and hyperlipidemia, who recently suffered class III effort-related angina and non-ST elevation MI, who presented with a totally occluded RCA, ulcerated LM, occluded LAD, and stenotic LCx, and study LIVE a complex PCI...

Complex PCI with left ventricular support

PCI calcified lesion - Session with LIVE case

06 Oct 2022 – From AICT-AsiaPCR 2022

Watch this LIVE case preceded by a discussion regarding the PCI of a calcified lesion on a 75-year-old male with hypertension and hyperlipidemia who presented with Class III angina. Non-invasive evaluation showed significant LAD and RCA disease, normal LVEF and no significant valvular disease...

PCI calcified lesion

Transcatheter mitral valve interventions: clinical outcomes 1

28 Nov 2022 – From PCR London Valves 2022

Consult this session on transcatheter mitral valve interventions to discover a selection of abstracts submitted during PCR London Valves 2022: one-year outcomes for transcatheter mitral repair from the MiCLASP study, the Edwards PASCAL transcatheter mitral valve repair system study, one-year outcomes of Tendyne TMVR treating symptomatic MR,...

Transcatheter mitral valve interventions: clinical outcomes 1

Mitral - Late-Breaking Trials and Innovations

28 Nov 2022 – From PCR London Valves 2022

Consult this session to discover a selection of late-breaking trials presented during PCR LV 2022: TENDyne European expeRience registry, CLASP IID trial, EXPAND G4, and much more!

Mitral - Late-Breaking

Imaging for mitral valve interventions

28 Nov 2022 – From PCR London Valves 2022

Thanks to this PCR LV 2022 session, find out more about outcome of patients undergoing transcatheter edge-to-edge mitral valve repair with HFpEF diagnosis.

Imaging for mitral valve interventions

Valve-in-valve TAVI: Session 2

28 Nov 2022 – From PCR London Valves 2022

Consult this session on Valve-in-valve TAVI to discover a selection of cases presented during PCR LV 2022: valve-in-valve TAVR status post ascending aorta and aortic arch replacement, valve-in-valve and endovascular treatment of aortic dissection in a Marfan patient, valve-in-valve TAVR in a freestyle root 25 mm through a severely...

Valve-in-valve TAVI: Session 2

TAVI in patients at risk of coronary occlusion

28 Nov 2022 – From PCR London Valves 2022

Consult this session on TAVI in patients at risk of coronary occlusion to discover a selection of cases presented during PCR LV 2022: hyperacute obstruction of the left main artery due to calcium displacement during TAVR, cannulation technique for challenging coronary access following TAVI-in-TAVI, complex TAVI from...

TAVI in patients at risk of coronary occlusion

Mitral: new devices and procedural refinements

28 Nov 2022 – From PCR London Valves 2022

Consult this session to discover a selection of cases regarding mitral new devices: transapical mitral valve implantation for treatment of symptomatic mitral valve disease, transcatheter edge-to-edge mitral valve repair for atrial functional mitral regurgitation, and much more!

Mitral: new devices and procedural refinements

Combined valve interventions

28 Nov 2022 – From PCR London Valves 2022

Among the very interesting cases presented in this PCR LV 2022 session, watch the 1st case of TMVR and TTVR in a patient with the use of dedicated investigational devices, simultaneous transcatheter mitral and tricuspid approach in a patient with dextrocardia, or simultaneous mitral valve-in-valve, tricuspid...

Combined valve interventions

Mitral complications

28 Nov 2022 – From PCR London Valves 2022

Because we can all be confronted with unexpected complications, this session of PCR LV 2022 proposes to study 5 specific cases such as an early redo mitral transcatheter edge-to-edge repair after single leaflet detachment or an unexpected cause of worsening dyspnoea after edge-to-edge mitral repair.

Mitral complications

How to achieve safe early discharge

29 Nov 2022 – From PCR London Valves 2022

Discover how to achieve safe early discharge for TAVI patients with these presentations: learn more about the need of pre-procedural planning and active post-procedural care, which ECG reading are a cause for concern, and much more!

How to achieve safe early discharge

Transcatheter mitral valve interventions: clinical outcomes 2

28 Nov 2022 – From PCR London Valves 2022

This PCR LV 2022 session will enable you to discover outcomes of transcatheter edge-to-edge MVR in patients with right ventricle dysfunction, TEER for MR early after myocardial infarction, or a predictive selection of patients for TMVR, among others!

Transcatheter mitral valve interventions: clinical outcomes 2

TAVI: technical considerations

28 Nov 2022 – From PCR London Valves 2022

Consult this session on TAVI technical considerations to discover a selection of cases presented during PCR LV 2022: transseptal snaring as a bailout from valvuloplasty balloon entrapment within a self-expanding valve, severe thrombocytopenia and severe aortic stenosis, embolisation of a fully deployed Evolute valve due to chest...

TAVI: technical considerations

TAVI complications: Session 3

28 Nov 2022 – From PCR London Valves 2022

Consult this session to discover how to manage various TAVI complications: complex iliofemoral artery dissection following TAVI, ruptured TAVI balloon, displacement of the transcatheter aortic valve prosthesis, and much more!

TAVI complications: Session 3

Clinical outcomes after TAVI: Session 2

29 Nov 2022 – From PCR London Valves 2022

Consult this session on the clinical outcomes after TAVI to learn more about the first results after commercial TAVI utilising the JenaValve Trilogy system for aortic stenosis and aortic regurgitation, the outcomes of contrast-zero TAVI vs. standard practice in patients with severe renal dysfunction, and more!

Clinical outcomes after TAVI: Session 2

Transcatheter edge-to-edge mitral valve repair step by step: from transseptal puncture to procedural success

28 Nov 2022 – From PCR London Valves 2022

Consult this session to learn how to perform a mitral transcatheter edge-to-edge repair procedure from start to finish, to learn more about currently available devices and which one to use in specific patients, and to understand how optimal procedural imaging and device steering determine the best...

Transcatheter edge-to-edge mitral valve repair step by step: from transseptal puncture to procedural success

TAVI in TAVI

29 Nov 2022 – From PCR London Valves 2022

Discover a selection of challenging cases in this session: valve-in-valve in a previous TAVR with healed endocarditis and aortic pseudoaneurysm closure, one-year SAPIEN 3 ultra failure treated with TAV-in-TAV with an Evolut Pro+ system, transcatheter valve implantation and coronary protection in a patient with prior valve-in-valve, and...

TAVI in TAVI

Mitral valve-in-valve interventions

Discover various compelling mitral valve-in-valve interventions in this session: bioprosthetic valve dislodgment during transapical valve-in-valve-TMVR, surgical bioprosthetic valve fracture for optimising haemodynamics of mitral valve-in-valve procedure, valve-in-valve TMVR in rheumatic mitral stenosis, and more!

Mitral valve-in-valve interventions

Surgical and transcatheter tricuspid intervention: state of the art - LIVE case

29 Nov 2022 – From PCR London Valves 2022

In this PCR London Valves 2022 session, follow 3 stunning case treatments:

  • Part 1: Triscupid TEER (Live)
    A 78-year-old male with a history of CABG (2015), PM-CRT (2015) and atrial fibrillation, presents a severe TR with an LVEF of 40%, preserved RV function and moderate pulmonary hypertension.
    They performed...
Surgical and transcatheter tricuspid intervention: state of the art
Didn’t find what you were looking for?